Real-life evidence in ERS clinical practice guidelines: From foes to friends

Markus Fally; Blin Nagavci; Thomy Tonia; Maarten van den Berge; Andrew Bush; Christopher Brightling; Nicolas Roche

doi:10.1183/13993003.01718-2021

Real-life evidence in ERS clinical practice guidelines: From foes to friends

Markus Fally, Blin Nagavci, Thomy Tonia, Maarten van den Berge, Andrew Bush, Christopher Brightling, Nicolas Roche^*

^*Corresponding author af dette arbejde

Lungemedicinsk Afd. L

5 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	2101718
Tidsskrift	European Respiratory Journal
Vol/bind	58
Udgave nummer	2
ISSN	0903-1936
DOI	https://doi.org/10.1183/13993003.01718-2021
Status	Udgivet - 1 aug. 2021

Adgang til dokumentet

10.1183/13993003.01718-2021

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{8d730c5b27314e1c9fd1534308440d99,

title = "Real-life evidence in ERS clinical practice guidelines: From foes to friends",

author = "Markus Fally and Blin Nagavci and Thomy Tonia and {van den Berge}, Maarten and Andrew Bush and Christopher Brightling and Nicolas Roche",

note = "Funding Information: Conflict of interest: M. Fally has nothing to disclose. B. Nagavci has nothing to disclose. T. Tonia acts as a methodologist for ERS. M. van den Berge has nothing to disclose. A. Bush has nothing to disclose. C. Brightling has nothing to disclose. N. Roche reports grants and personal fees from Boehringer Ingelheim, Novartis, GSK and Pfizer, personal fees from AstraZeneca, Chiesi, Sanofi and Zambon, outside the submitted work.",

year = "2021",

month = aug,

day = "1",

doi = "10.1183/13993003.01718-2021",

language = "English",

volume = "58",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "2",

}

TY - JOUR

T1 - Real-life evidence in ERS clinical practice guidelines

T2 - From foes to friends

AU - Fally, Markus

AU - Nagavci, Blin

AU - Tonia, Thomy

AU - van den Berge, Maarten

AU - Bush, Andrew

AU - Brightling, Christopher

AU - Roche, Nicolas

N1 - Funding Information: Conflict of interest: M. Fally has nothing to disclose. B. Nagavci has nothing to disclose. T. Tonia acts as a methodologist for ERS. M. van den Berge has nothing to disclose. A. Bush has nothing to disclose. C. Brightling has nothing to disclose. N. Roche reports grants and personal fees from Boehringer Ingelheim, Novartis, GSK and Pfizer, personal fees from AstraZeneca, Chiesi, Sanofi and Zambon, outside the submitted work.

PY - 2021/8/1

Y1 - 2021/8/1

UR - http://www.scopus.com/inward/record.url?scp=85112167945&partnerID=8YFLogxK

U2 - 10.1183/13993003.01718-2021

DO - 10.1183/13993003.01718-2021

M3 - Journal article

C2 - 34353865

AN - SCOPUS:85112167945

VL - 58

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 2

M1 - 2101718

ER -